Relationship between body mass index and outcomes in patients with atrial fibrillation treated with edoxaban or warfarin in the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi… - European heart …, 2019 - academic.oup.com
Aims To investigate the relationship between body mass index (BMI) and outcomes in
patients with atrial fibrillation (AF). Methods and results In the ENGAGE AF-TIMI 48 trial …

Edoxaban versus warfarin in patients with atrial fibrillation at the extremes of body weight: an analysis from the ENGAGE AF-TIMI 48 trial

G Boriani, CT Ruff, JF Kuder, M Shi… - Thrombosis and …, 2021 - thieme-connect.com
Background The effects of anticoagulants at extremes of body weight (BW) are not well
described. The aim of this study was to analyze the pharmacokinetics/pharmacodynamics …

Body mass index and adverse outcomes in elderly patients with atrial fibrillation: the AMADEUS trial

K Senoo, GYH Lip - Stroke, 2016 - Am Heart Assoc
Background and Purpose—Obesity has been associated with increased cardiovascular risk
in atrial fibrillation, but little is known in elderly patients with atrial fibrillation. Methods—Post …

The 'obesity paradox'in atrial fibrillation: observations from the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) …

RK Sandhu, J Ezekowitz, U Andersson… - European heart …, 2016 - academic.oup.com
Aims The prognostic implication of adiposity on clinical outcomes in atrial fibrillation (AF)
patients treated with oral anticoagulation is unclear. Methods and results A total of 17 913 …

Relation of risk of stroke in patients with atrial fibrillation to body mass index (from patients treated with rivaroxaban and warfarin in the rivaroxaban once daily oral …

SR Balla, DD Cyr, Y Lokhnygina, RC Becker… - The American journal of …, 2017 - Elsevier
We investigated stroke outcomes in normal weight (body mass index [BMI] 18.50 to 24.99
kg/m 2), overweight (BMI 25.00 to 29.99 kg/m 2), and obese (BMI≥ 30 kg/m 2) patients with …

Relation of body mass index with adverse outcomes among patients with atrial fibrillation: a meta‐analysis and systematic review

W Zhu, R Wan, F Liu, J Hu, L Huang, J Li… - Journal of the American …, 2016 - Am Heart Assoc
Background Several studies have investigated the impact of body mass index (BMI) on the
prognosis of atrial fibrillation, but the results remain controversial. We sought to estimate the …

Efficacy and safety of direct oral anticoagulants versus warfarin in patients with atrial fibrillation across BMI categories: a systematic review and meta-analysis

Y Zhou, J Ma, W Zhu - American Journal of Cardiovascular Drugs, 2020 - Springer
Objectives Concerns have arisen recently over the relationship between body mass index
(BMI) and outcomes in atrial fibrillation (AF) patients with direct oral anticoagulants (DOACs) …

Is There an Obesity Paradox for Outcomes in Atrial Fibrillation? A Systematic Review and Meta-Analysis of Non–Vitamin K Antagonist Oral Anticoagulant Trials

M Proietti, E Guiducci, P Cheli, GYH Lip - Stroke, 2017 - Am Heart Assoc
Background and Purpose—Obesity is a risk factor for all-cause and cardiovascular death
but, despite this, an inverse relationship between overweight or obesity and a better …

[HTML][HTML] Effects of body mass index on risks for ischemic stroke, thromboembolism, and mortality in Chinese atrial fibrillation patients: a single-center experience

HJ Wang, QJ Si, ZL Shan, YT Guo, K Lin, XN Zhao… - PLoS …, 2015 - journals.plos.org
Background Obesity is considered to be related to recurrence of atrial fibrillation (AF), left
atrial thrombus formation, and atrial remodeling. However, whether obesity is an …

Impact of body mass index on the prognosis of Japanese patients with non-valvular atrial fibrillation

H Inoue, E Kodani, H Atarashi, K Okumura… - The American Journal of …, 2016 - Elsevier
Obesity is a risk factor for atrial fibrillation (AF); however, obesity is associated with lower
mortality in patients with established AF, a phenomenon known as the obesity paradox …